Healthcare

Healthcare is constantly changing and functions in a variety of dynamic structures. The healthcare industry includes companies that provide medical services, manufacture medical devices and medicines, provide medical insurance and otherwise alleviate the healthcare needs of patients. The healthcare industry is experiencing rapid technological advances, infrastructure development and a growing demand for low-cost, pocket-friendly diagnostics and treatments. Today, with the internet, every stage of diagnosis and treatment has become transparent, personalised and a sophisticated experience for pa...tients. The healthcare industry is increasingly turning to hospitals, pharmaceutical companies and other health professionals for more comprehensive solutions that go beyond medicines. It also includes the provision of training to health professionals, as well as the management and operation of health services. Healthcare companies are trying to rise above the competition to keep pace with changing forms of scientific and technological advances, government regulations and the needs of patients. Astute Analytica offers a wide range of services as well as addressing the usual issues facing the healthcare industry. Modernisation of infrastructure and services is taking the healthcare industry to new heights. Economic development and increased patient awareness in emerging economies have modernised healthcare in these countries. Government support and healthcare reform have also contributed to the success of companies in the healthcare industry. Innovative research and patient-centred solutions are highly valued by the entire healthcare research sector.

Health Care Equipment & Services

Pharmaceuticals, Biotechnology & Life Sciences

Report ID: AA08251475 | 26-Aug-2025 | 280 Pages

Central Nervous System Therapeutic Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Central nervous system therapeutic market was valued at US$ 129.38 billion in 2024 and is projected to hit the market valuation of US$ 235.87 billion by 2033 at a CAGR of 6.90% during the forecast period 2025–2033.

Report ID: AA08251474 | 26-Aug-2025 | 240 Pages

Saliva Collection and Diagnostics Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Saliva collection and diagnostics market was valued at US$ 826.6 million in 2024 and is projected to hit the market valuation of US$ 1,260.5 million by 2033 at a CAGR of 4.8% during the forecast period 2025–2033.

Report ID: AA08251466 | 23-Aug-2025 | 240 Pages

Viral Vectors & Plasmid DNA Manufacturing Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast period 2025–2033.

Report ID: AA08251458 | 19-Aug-2025 | 240 Pages

Human Osteoblasts Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Human osteoblasts market was valued at US$ 48.2 million in 2024 and is projected to hit the market valuation of US$ 87.1 million by 2033 at a CAGR of 6.8% during the forecast period 2025–2033.

Report ID: AA08251456 | 17-Aug-2025 | 260 Pages

Advanced Ophthalmology Technology Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Advanced ophthalmology technology market was valued at US$ 8.78 billion in 2024 and is projected to hit the market valuation of US$ 16.01 billion by 2033 at a CAGR of 6.9% during the forecast period 2025–2033.

Report ID: AA08251454 | 17-Aug-2025 | 240 Pages

Digital Health In Neurology Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Digital health in neurology market was valued at US$ 38.9 billion in 2024 and is projected to hit the market valuation of US$ 229.5 billion by 2033 at a CAGR of 21.8% during the forecast period 2025–2033.

Report ID: AA08251447 | 13-Aug-2025 | 140 Pages

U.S. mRNA Therapeutics CDMO Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $1800

US mRNA therapeutics CDMO market was valued at US$ 1.78 billion in 2024 and is projected to hit the market valuation of US$ 6.27 billion by 2033 at a CAGR of 15.01% during the forecast period 2025–2033.

Report ID: AA08251436 | 09-Aug-2025 | 105 Pages

Japan Colposcopy Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $1800

Japan colposcopy market was valued at US$ 37.84 million in 2024 and is projected to hit the market valuation of US$ 66.23 million by 2033 at a CAGR of 6.70% during the forecast period 2025–2033.

Report ID: AA08251430 | 04-Aug-2025 | 310 Pages

Phosphoramidite Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Phosphoramidite market was valued at US$ 1.21 billion in 2024 and is projected to hit the market valuation of US$ 2.44 billion by 2033 at a CAGR of 8.1% during the forecast period 2025–2033.

Report ID: AA08251429 | 03-Aug-2025 | 210 Pages

Left Atrial Appendage Closure Devices Market - Industry Dynamics, Market Size and Opportunity Forecast To 2033 $4250

Left atrial appendage closure devices market was valued at US$ 1.98 billion in 2024 and is projected to hit the market valuation of US$ 9.40 billion by 2033 at a CAGR of 18.9% during the forecast period 2025–2033.